+$96 Billion Opportunity for the Global Precision Medicine Market by 2023 - Featuring Abbott Labs, GE, GSK, Pfizer, J&J, Novartis, and more - ResearchAndMarkets.com

DUBLIN--()--The "Global Precision Medicine Market (2018-2023)" report has been added to ResearchAndMarkets.com's offering.

The global precision medicine market is expected to have a significant compounded annual growth rate (CAGR) of 9.7% and have a market size in excess of USD 96 Bn by 2023. North America dominates the global market due to the high incidence of cancer and increasing government initiatives in the region.

The global precision medicine market is classified into three primary segments - based on end use: pharmaceuticals and biotech companies, clinical laboratories, diagnostic companies and healthcare IT specialists/big data companies; based on therapeutics: cancer, cardiovascular, central nervous system, psychiatric disorder and infectious diseases; and based on sub-market: big data analytics, bioinformatics, gene sequencing, pharmacogenomics and companion diagnostics.

The concept of precision medicine has gained momentum in the healthcare community, powered by the tremendous expansion of various advanced technologies such as next-generation sequencing, molecular biomarker analysis and many more. Technological advancements have helped the precision medicine market prevent as well as treat diseases such as cancer, cardiovascular, neurology, diabetes, and others.

Rising pressure to lower healthcare cost globally, growth of personal healthcare devices, the emergence of value-based reimbursement models, and healthcare digitization trends are aiding the transition of treatment model from one-size-fits-all' to stratified and outcome-based targeted therapies, which are called precision medicine.

Threat to personal data, high diagnostic costs, and the risk of hardware and software failure are some of the factors that will hinder the growth of the market.

Companies Featured

  • Abbott Laboratories
  • GE Healthcare
  • GlaxoSmithKline (GSK)
  • Johnson & Johnson
  • Pfizer
  • Randox Laboratories
  • Almac Group
  • Novartis AG
  • Teva Pharmaceuticals Limited
  • CETICS Healthcare Technologies GmbH

Key Topics Covered

Chapter 1. Executive Summary

Chapter 2. Global Precision Medicine Market - Market Overview

Chapter 3. North America Precision Medicine Market - Market Overview

Chapter 4. Europe Precision Medicine Market - Market Overview

Chapter 5. Asia-Pacific Precision Medicine Market - Market Overview

Chapter 6. Latin America Precision Medicine Market - Market Overview

Chapter 7. Middle East & Africa Precision Medicine Market - Market Overview

Chapter 8. Competitive Landscape

Chapter 9. Conclusion

For more information about this report visit https://www.researchandmarkets.com/research/3twz5p/96_billion?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Genomics